These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Helicobacter pylori and bismuth subnitrate. Sodeman WA Am J Gastroenterol; 1990 Sep; 85(9):1200-1. PubMed ID: 2389738 [No Abstract] [Full Text] [Related]
16. Bacteriological and pharmacological basis for the treatment of Campylobacter pylori infection. McNulty CA Gastroenterol Clin Biol; 1989; 13(1 Pt 1):96B-100B. PubMed ID: 2663605 [No Abstract] [Full Text] [Related]
17. [Dose-effect studies with bismuth salts for the elimination of Campylobacter pylori]. Menge H; Hofmann J; Gregor M Z Gastroenterol; 1987 Sep; 25 Suppl 4():44-6. PubMed ID: 3318192 [No Abstract] [Full Text] [Related]
18. The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: a placebo-controlled, randomized study. Lanza FL; Skoglund ML; Rack MF; Yardley JH Am J Gastroenterol; 1989 Sep; 84(9):1060-4. PubMed ID: 2773899 [TBL] [Abstract][Full Text] [Related]
19. Campylobacter pylori: its role in gastritis and peptic ulcer disease. Hornick RB Curr Clin Top Infect Dis; 1989; 10():157-73. PubMed ID: 2679692 [No Abstract] [Full Text] [Related]
20. Effect of oral bismuth subsalicylate on Campylobacter pylori and on healing and relapse rate of peptic ulcer. Eberhardt R; Kasper G Rev Infect Dis; 1990; 12 Suppl 1():S115-9. PubMed ID: 2406852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]